City

Houston (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

M.D. Anderson Cancer Center (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

cladribine (1)

cytarabine (1)

gilteritinib (1)

idarubicin (1)

laboratory biomarker analysis (1)

midostaurin (1)

venetoclax (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Other (1)

Study Type

Interventional (1)

blasts 10 percent or more of peripheral blood white cells

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

Recruiting

Acute Biphenotypic Leukemia
+13 more

Cladribine
+6 more

Houston, Texas

M D Anderson Cancer Center

Jan 19, 2023